🇺🇸 FDA
Pipeline program

Placebo of NAL, NACYSTELYN

NAL-II-23-1

Phase 2 small_molecule active

Quick answer

Placebo of NAL, NACYSTELYN for Obstructive Sleep Apnea is a Phase 2 program (small_molecule) at Laboratoire HRA Pharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Laboratoire HRA Pharma
Indication
Obstructive Sleep Apnea
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials